CALM news

Cal-Maine Foods reported a significant decline in net sales and income driven by low conventional egg pricing. However, it offset losses with high-growth Specialty and Prepared Foods segments and an Eggland's Best acquisition.

Cal-Maine Foods Inc. entered into a Second Amended and Restated Credit Agreement, replacing an existing agreement and tying future borrowing costs to the Secured Overnight Financing Rate.

Cal-Maine reported a net loss of $35.9 million for Q4 and $316.7 million for fiscal 2026, driven by a drastic decline in shell egg sales volume. Despite this, the company continued its shift toward diversified revenue streams, including prepared foods and specialty eggs.

CalciMedica filed a document detailing a form for a pre-funded warrant to purchase common stock. This indicates potential equity-related activity without immediate disclosure of earnings or other financial metrics.

Cal-Maine Foods has appointed two independent directors, expanding its board to ten members. The move strengthens the company's governance and strategic oversight as it pursues growth in the egg industry.